Related Experiment Video
Updated: Aug 5, 2026

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
Published on: September 17, 2019
A Bifunctional Artificial Antibody for Universal Antimicrobial Therapy
Hao Tang1, Xiaomeng Zhao1, Mengsi Sun2
1Guangdong Provincial Key Laboratory of Advanced Biomaterials, Shenzhen Key Laboratory of Smart Healthcare Engineering, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong, P. R. China.
Chemically engineered AuriFAB biomimetic antibodies offer a universal solution against multidrug-resistant ESKAPE pathogens. This stable, bifunctional therapy targets key bacterial components, overcoming limitations of traditional antibody treatments for antimicrobial resistance.
Area of Science:
- Biomaterials Science
- Chemical Biology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) is a critical global health challenge.
- Multidrug-resistant ESKAPE pathogens are a major threat to public health.
- Existing antibody therapies face limitations in stability and functional diversity.
Purpose of the Study:
- To develop a universal antimicrobial therapy against multidrug-resistant ESKAPE pathogens.
- To engineer a chemically stable and functionally diverse antibody biomimetic.
- To address the limitations of traditional biological antibacterial antibodies.
Main Methods:
- Chemical engineering of a gold-based bifunctional antibody biomimetic (AuriFAB).
- Utilized dithiocarbamate ligation for enhanced stability.
- Employed chemical epitope screening for bispecific targeting (FtsZ and lipopolysaccharide).
Main Results:
- AuriFAB demonstrated exceptional colloidal and long-term storage stability (>1 year).
- Engineered AuriFAB achieved picomolar binding affinity and nanogram-per-milliliter antibacterial efficacy.
- AuriFAB showed low toxicity, high selectivity, favorable pharmacokinetics, and metabolizable clearance.
Conclusions:
- AuriFAB provides a universal solution against multidrug-resistant ESKAPE pathogens.
- This chemical strategy overcomes the stability and functionality limitations of biological antibodies.
- Chemistry-driven biologic mimics hold significant therapeutic potential for combating AMR.
Related Concept Videos
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Humoral Immune Responses
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

